4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001915598-26-000004
Chief Commercial Officer sold 226 shares at $26.28 ($5,939)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Friedl-Naderer Johanna · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-13 | Sale : show line 1 in the form 10b5-1 | −226 | $26.28 | $5,939 | 153,982 | D |
| Open-market sales · 226 sh · avg $26.28 · $5,939 | ||||||
Loading xslF345X06/ownership.xml…